KalVista Pharmaceuticals, Inc. (KALV)
16.15
+0.47
(+3.00%)
USD |
NASDAQ |
Dec 31, 16:00
16.18
+0.03
(+0.19%)
After-Hours: 20:00
KalVista Pharmaceuticals Market Cap: 816.32M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| BioCryst Pharmaceuticals, Inc. | 1.642B |
| Silvergate Capital Corp. | 294.60M |
| Perspective Therapeutics, Inc. | 204.43M |
| Electromed, Inc. | 242.88M |
| Xtant Medical Holdings, Inc. | 109.76M |
Market Cap Related Metrics
| PS Ratio | 56.03 |
| PEG Ratio | -0.3934 |
| Price to Book Value | 48.02 |
| Price | 16.15 |
| Earnings Yield | -24.85% |
| PEGY Ratio | -0.3934 |